This inventor holds 1 USPTO granted patent. Top assignee: Globomax LLC. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of William R. Gillespie
Introduction
William R. Gillespie is a notable inventor based in Apex, NC (US). He has made significant contributions to the field of biological modeling, particularly through his innovative patent that enhances the understanding of drug absorption and release.
Latest Patents
Gillespie holds a patent for a "Tool for in vitro-in vivo correlation." This invention provides a biological modeling system and method for enhanced computer-aided analysis of biological response data. The system synthesizes information from both immediate and extended release in vivo data and in vitro data. A two-stage approach to modeling is utilized, where the first stage involves deconvolution to determine the percentage of drug absorbed. The second stage correlates the in vivo percentage absorbed data to the in vitro fraction or percentage dissolved data. This correlation establishes a point-to-point relationship between in vitro dissolution and in vivo input rate of the drug from the dosage form. The model also incorporates a nonlinear IVIVC that can adjust for time-scaling and time-shifting as needed. The predictability of the developed model is evaluated through both internal and external validation.
Career Highlights
Gillespie's career is marked by his dedication to advancing the field of pharmacokinetics through innovative modeling techniques. His work has implications for improving drug formulation and delivery, ultimately benefiting patient care and therapeutic outcomes.
Collaborations
Gillespie has collaborated with notable colleagues, including Theresa A. Shepard and Sian E. Bigora, who have contributed to his research and development efforts.
Conclusion
William R. Gillespie's innovative work in biological modeling and drug absorption has made a significant impact in the field. His patent reflects a commitment to enhancing the understanding of pharmacokinetics, paving the way for advancements in drug development and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile